An updated review on complicated mechanisms of COVID-19 pathogenesis and therapy: direct viral damage, renin-angiotensin system dysregulation, immune system …

S Falahi, M Maleki, A Kenarkoohi - Infectious Disorders-Drug …, 2022 - ingentaconnect.com
SARS-CoV-2 was reported as the cause of coronavirus disease 2019 (COVID-19) in late
December 2019. According to sequencing and phylogenetic studies, the new virus belongs …

Platelet activation and thrombosis in COVID-19

T Iba, H Wada, JH Levy - Seminars in Thrombosis and …, 2023 - thieme-connect.com
Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated
with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19 …

Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19

E Azouz, S Yang, L Monnier-Cholley, L Arrivé - Intensive care medicine, 2020 - Springer
A 56-year-old patient was admitted in our institution for an acute ischemic stroke due to the
occlusion of the right middle cerebral artery. Angio-CT scan performed upon admission …

Pathological findings in organs and tissues of patients with COVID-19: A systematic review

S Peiris, H Mesa, A Aysola, J Manivel, J Toledo… - PloS one, 2021 - journals.plos.org
Background Coronavirus disease (COVID-19) is the pandemic caused by SARS-CoV-2 that
has caused more than 2.2 million deaths worldwide. We summarize the reported pathologic …

Acute coronary thrombosis as a complication of COVID-19

L Genovese, D Ruiz, B Tehrani… - BMJ Case Reports …, 2021 - casereports.bmj.com
COVID-19 has varied cardiovascular manifestations including microvascular and
macrovascular thrombi leading to multiorgan system injury and failure. This case describes …

Acute myocardial infarction and large coronary thrombosis in a patient with COVID‐19

D Tedeschi, A Rizzi, S Biscaglia… - Catheterization and …, 2021 - Wiley Online Library
This is a case report of a 60‐year‐old male, without any cardiovascular risk factor and no
cardiac history admitted to hospital with a diagnosis of interstitial pneumonia caused by …

Risk management and treatment of coagulation disorders related to COVID-19 infection

C Zanza, F Racca, Y Longhitano, A Piccioni… - International Journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease. Bilateral
pneumonia, acute respiratory failure, systemic inflammation, endothelial dysfunction and …

COVID-19 and the Response to Antiplatelet Therapy

T Bolek, M Samoš, J Jurica, L Stančiaková… - Journal of Clinical …, 2023 - mdpi.com
The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity
and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets …

COVID‐19 associated thrombosis and coagulopathy: review of the pathophysiology and implications for antithrombotic management

L Ortega‐paz, D Capodanno… - Journal of the …, 2021 - hal.sorbonne-universite.fr
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) which has posed a significant threat to …

The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options

S Choudhary, K Sharma, O Silakari - Microbial pathogenesis, 2021 - Elsevier
Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …